Task: Answer the multiple choice question.
Question: Which drug exhibits a -21.744% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
(a) CN(C)S(=O)(=O)c1ccc(NC(=O)CN2C(=O)NC3(CCCC3)C2=O)cc1
(b) COC(=O)c1cc(Nc2cc(C)c3c(O)cccc3n2)cc(C(=O)OC)c1
Answer: b. COC(=O)c1cc(Nc2cc(C)c3c(O)cccc3n2)cc(C(=O)OC)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COC(=O)c1cc(Nc2cc(C)c3c(O)cccc3n2)cc(C(=O)OC)c1
COC(=O)c1cc(Nc2cc(C)c3c(O)cccc3n2)cc(C(=O)OC)c1
dimethyl 5-[(5-hydroxy-4-methylquinolin-2-yl)amino]benzene-1,3-dicarboxylate